Skip to main content
. 2017 Jun 24;10(4):546–554. doi: 10.1016/j.tranon.2017.05.007

Figure 3.

Figure 3

High nuclear expression of survivin in MLS. Immunohistochemical analysis of nuclear survivin expression in 32 MLS patients showing high expression in tumor components with myxoid, intermediate, and round cell morphology (A). High nuclear survivin expression in tumor with myxoid morphology (B). High nuclear survivin expression in tumor with round cell morphology (C) (20× magnification).